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Information on the in vitro sensitivity of Mycobacterium tuberculosis to pyrazinamide
is limited, mainly because of the difficulty in choosing an appropriate pH for the medium
employed. A pyrazinamide sensitivity test, employing Lowenstein-Jensen medium
acidified with hydrochloric acid to a preinspissation pH of 4.80-4.85, was developed at
this Centre, and performed on cultures from tuberculous patients. Sensitivity was
measured as the minimal inhibitory concentration (MIC) of pyrazinamide for various
sires of the inoculum, and as proportions of the bacterial population resistant to various
concentrations of the drug.For each measure, the findings in patients with no history
of previous chemotherapy with pyrazinamide were compared with those obtained at 4-12
months after the start of daily treatment with pyrazinamide ; the definition of resis-
tance was chosen such that it discriminated efficiently between the twopopulations,
and classified only a small proportion of the former population as resistant. Four
definitions of resistance were chosen–an MIC of 200 µg/ml or more employing an
inoculum containing approximately 0.4 mg of bacilli per ml and a 10-colony end-point,
and proportions of 20 % or more on 25 µg/ml, 5 % or more on 50 µg/ml, and 1% or more
on 100 µg/ml.The four definitions were of similar efficiency.Employing them, it was
found that wild strains with consistent resistance to pyrazinamide were rare in Madras
patients ; also, in patients who received daily pyrazinamide, resistance emerged (if at
all) at 4-6 months after the start of treatment.
Introduction
Pyrazinamide was first reported to have antituberculosis activity in the mouse
(Kushner et al 1952, Malone et al 1952), but to be devoid of in vitro activity against
Mycobacterium tuberculosis (Tarshis and Weed 1953, Schwartz and Moyer 1954, Steenken
and Wolinsky 1954).Later studies revealed, however, that the drug did exert activity
in vitro, but only in acid medium of pH 5.0-5.5 (McDermott and Tompsett 1954).
Several acid media have since been used for pyrazinamide sensitivity tests (Canetti,
Rist and Grosset 1963, Marks 1964, Stottmeier, Beam and Kubica 1967), but it has
always been difficult to choose an appropriate pH for the medium such that pyrazina-
mide is active and as few aspos ible of the test strains are inhibited solely by the acidity
of the medium.In consequence, there is limited information on the n vitro sensitivity
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of M. tuberculosis to pyrazinamide and on the emergence of pyrazinamide resistance
during treatment with the drug.
In a preliminary study at this Centre, fluid acid media were found to be unsatis-
factory since many strains of tubercle bacilli failed to grow in them.Three solid media–
Steenken and Smith’s acid medium (United States Veterans Administration 1960)
Lowenstein-Jensen medium acidified with hydrochloric acid and Lowenstein-Jensen
medium acidified with citric acid were, therefore, compared for their ability to sustain
the growth of tubercle bacilli ; all three media had a pre-inspissation pH of 5.1 and a
post-inspissation pH of 5.4-5.5. It was found that the Lowenstein-Jensen medium
acidified with hydrochloric acid yielded the most satisfactory growth of tubercle bacilli.
Furthermore, this medium, at its normal pH, is employed for all other drug sensitivity
tests at this Centre.Therefore, further experimentation was restricted to the Lowen-
stein-Jensen medium acidified with hydrochloric acid. A comparative study of
this medium at three pH levels, namely 4.80, 4.95 and 5.10 showed that the pH of 4.80
was the best, in terms of demonstrating the activity of the drug and sustaining the
growth of tubercle bacilli. For all subsequent tests the medium employed had a
pre-inspissation pH of 4.80-4.85.
The present report is based on the findings of pyrazinamide sensitivity tests under-
taken at this Centre since 1963, and compares the relative efficiency of various measures
of sensitivity (minimal inhibitory concentrations, proportions resistant) in detecting
resistance to pyrazinamide ; an interim report was presented earlier (Tripathy 1966).
Material and Methods
Strains : The following cultures of M. tuberculosis were tested :
Wild (W) cultures : A pair of cultures,obtained before the start of chemo-
therapy, from each of 222 newly-diagnosed tuberculous patients admitted to a
chemotherapy study at this Centre.All the cultures were sensitive to isoniazid and
streptomycin according to standard definitions (Tuberculosis Chemotherapy Centre
Madras 1959). For all analyses other than the one on variation between duplicate
cultures, only the results on the first culture from each patient have been considered.
Failure (F) cultures : Cultures from patients who were treatment failures of
one or more regimens not including pyrazinamide, at this Centre. Over a period
of one year, 51 such cultures were tested from the same number of patients, and of
these, 34 were resistant to isoniazid.
Probably resistant (PR) cultures : Cultures isolated from patients during treatment
(1-12 months) with regimens containing pyrazinamide in a single daily dose of 1.0 to
1.5 g. In all, 154 cultures were obtained from 55 such patients (all of them were
treatment failures of one or more regimens at this Centre), and tested over the same
period as the F cultures.
British cultures : A sample of 25 cultures, obtained before the start of chemo-
therapy, from the same number of British patients with newly-diagnosed pulmonary
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tuberculosis.The sample was obtained by random selection from cultures sensitive
to isoniazid and streptomycin (according to standard definitions) in a national survey
of the prevalence of drug resistance in Britain (Miller et al 1966).
H37Rv : The sensitivity of the standard strain, H37Rv, was determined in each
batch of pyrazinamide medium, the total number of tests was 86.
Medium and drug concentrations : Acidified Lowenstein-Jensen medium with a pre-
inspissation pH of 4.80-4.85 was employed.This was prepared by mixing the
basic ingredients of Lowenstein-Jensen medium (Cruickshank 1965), and adding appro-
ximately 20 ml of 2N hydrochloric acid per litre of the medium ; the pH was then adjusted
employing a pH meter with a glass electrode.
The concentrations of pyrazinamide employed were 12.5, 25, 50 and 100 µg/ml.
Both the drug-containing medium and the drug-free (control) medium were distributed
in 7 ml quantities in 1 oz screw-capped Universal containers and inspissated at 85°C
for 50 min.The pH of the medium after inspissation ranged from 5.10 to 5.20.
Lowenstein-Jensen medium at its normal pH (6.8 to 7.0) was also employed, in
order to determine the effect of acidification of the medium on the growth of the strains.
Sensitivity tests : The sensitivity tests were of the indirect type and were undertaken
on the primary isolates in the case of the W, F and PR strains, and on subcultures in
the case of the H37Rv and British strains.Approximately 4 mg (moist weight) of
growth, as judged by eye, was taken with a 22-SWG nichrome loop and placed in a
4 oz screw-capped bottle containing 12 3-mm diameter glass beads and 0.2 ml distilled
water. After shaking the bottle for 1 min, 0.8 ml distilled water was added to obtain a
suspension containing approximately 4 mg of bacilli per ml (S1). Four successive
10-fold dilutions (S2, 3, S4 and S5) were then prepared by adding appropriate amounts
of distilled water.One loopful (27 SWG nichrome, 3-mm external diameter) from each
of the suspensions, S1, S2, S3 and S4 inoculated on to slopes containing pyrazina-
mide 12.5, 25, 50 and 100 µg/ml (Table I).As controls, one drug-free acidified Lowen-
stein-Jensen slope was inoculated with the suspension S1, one with the suspension S2 and
2 each with the suspensions S3, S4 and S5. Drug-free slopes of normal Lowenstein-
Jensen medium were also set up in parallel as further controls.
Particular care was taken not to dig the loop below the surface of the softacid
medium, and not to inoculate into the water of condensation or on to the medium
immediately adjoining the glass surface.The slopes were incubated at 37°C and
examined 40 days later.
The minimal concentrations of the drug inhibiting growth (MICs) on slopes ino-
culated with suspensions S1, S2 and S3 were determined.For this purpose, growth was
defined as the appearance of 20 or more colonies on slopes inoculated with the S1
suspension 10 or more colonies with the S2 susp nsion and 5 or more colonies with the
S3 suspensions (If there was growth on the 100 µg/ml pyrazinamide slope–the
highest concentration employed in this study–the MIC was regarded as 200 µg/ml or
more).
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Table I. An example of the findings of the pyrazinamide sensitivity test*
Suspension
Next, the proportions of the bacterial population resistant to different concentra-
tions of pyrazinamide (12.5, 25, 50 and 100 µg/ml)were determined. For this purpose,
the number of colonies on the drug-containing slope inoculated with the S1 suspension
was estimated, and expressed as a percentage of the estimated number of colonies on the
acidified drug-free S1 slope. The counts selected for estimation purposes were, in the
order of preference, 20-70, 5-19 and more than 70 colonies on the drug-free slopes (the
mean count was considered for the S3, S4 and S5 suspensions),and 5-100, 0-4 and more
than 100 colonies on the drug-containing slopes.If more than one suspension yielded
satisfactory counts with the drug-containing medium, the count on the suspension closest
to the one selected for estimating the bacterial population on the drug-free S1 slope was
chosen.When the satisfactory count was zero with the drug-containing medium, the
proportion resistant was calculated assuming that one colony grew on the heaviest of the
suspensions with the zero colony count (usually S1) and the result expressed as less than
this proportion.When classifying individual cultures as sensitive or resistant, such a
result was excluded from the analysis if the proportion was higher than the critical
proportion signifying resistance.
An example of the findings of the pyrazinamidesensitivity test is set out in Table I,
together with the various measures of sensitivity derived from them.
Growth on acidified drug-free medium :Of 538 cultures that grew on normal drug-free
medium, only 4 failed to grow on acidified drug-free medium (Table II).
Considering the remaining 534 cultures, the growth on the acidified medium was less
than 50% of the growth on the normal medium for 147 (28 %).Finally, the mean viable
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count in the acidified medium (1.2 x 104) was appreciably less than that in the normal
medium (2.0 x 104).
Table II. Comparison of growth on normal and acidified drug-free Lowenstein-Jensen medium
Cultures with growth on acidified medium
I
Type of
culture
Cultures with Growth on acidified medium
no growth on expressed as a percentage ofMean viable count
acidified growth on normal medium
medium Total
Less
than 10  10– 50–
100 or Acidified Normal
more medium medium
Madras W
Madras F
Madras PR
British
H37Rv
All cultures
Considering pre-treatment strains, there was evidence that British cultures grew
less well than Madras ‘cultures, especially in acidified medium. Thus, the mean viable
count in normal medium was 1.8 x 104 for the British and 2.5 x 104 for the Madras
cultures, and the corresponding mean counts in acidified medium were 0.4 x 104 and
1.8 x 104, respectively.Lastly, the growth on the acidified medium was 50 % or more of
the growth on the normal medium for 12 (48 %) of 25 British cultures as compared with
179 (81%) of 222 Madras cultures, a highly significant difference (P < 0.001).
Sensitivity, expressed as an MIC, of different types of cultures : It will be recalled
that the W, F and British cultures were all isolated from patients who had no history of
previous chemotherapy with pyrazinamide, and that the PR cultures were obtained from
patients at 1-12 months after the start of treatment with daily pyrazinamide.There-
fore, the former group would have consisted predominantly of pyrazinamide-sensitive
cultures while the latter is likely to have included an appreciable proportion of pyra-
zinamide-resistant cultures.
Table III sets out the cumulative distributions of various types of cultures accord,
ing to the S1-MIC, the S2-MIC and the S3-MIC. The total number of results available
is slightly smaller than the number of tests set up, partly because of contamination
but mainly due to the growth on the control slopes being insufficient for determining the
MIC. In all, the S1-MIC could not be determined for 8 (1.5 %) of 534 cultures tested,
the S2-MIC for 19(3.6 %) and the S3-MIC for 41 (7.7 %) cultures.
In general, the W cultures and F cultures had similar distributions.The amal-
gamated group of cultures (W +F), however, was less sensitive than the British cultures
and the strain H37Rv.For instance, 83 % of 268 W+F cultures had an S1-MIC of
Table III. Cumulative distribution of cultures according to minimal inhibitory concentrations at 40 days
Suspension
and MIC
 end-point  ( µ g / m l )
 Duration (months) of chemotherapy
No chemotherapy with pyrazinamide with pyrazinamide
(PR cultures)
No. of cultures     80      15 2 1 3 44 257 51 47 43 90
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25 µg/ml or more as compared with 57 % of 21 British cultures (P < 0.01) and 62%
of 84 tests on the strain H37Rv (P< 0.01).
Considering next the PR cultures, those isolated at 1-3 months were of the same
order of sensitivity as the W+F cultures.However, PR cultures isolated at 4-6 months
and 7-12 months were substantially less susceptible.For instance;48 % of 96 PR cultures
isolated at 4-12 months had an S2-MIC of 200 µg/ml or more as compared with 8%
of 265 W+F cultures (P< 10-s) and 8% of 52 PR cultures isolated at l-3 months
(P<10-5) .
The findings in W+F cultures and PR cultures isolated at 4-12 months formed
the basis for evolving definitions of pyrazinamide resistance in Madras Cultures.
Considerations involved in the choice of definitions of resistance:Two onsiderations
were involved in the choice of definitions of resistance.These were (1) the definition
should discriminate efficiently between the W+F cultures on the one hand and the PR
4-12 cultures on the other hand, and (2) the proportion of W+F cultures that are classi-
fied as resistant should be small, as pyrazinamide has hardly been used in Madras city.
Definitions of resistance based on MICs for different suspensions :Several definitions
of resistance (Table III, column 2) were considered ; their ability to discriminate between
the W+F cultures and the PR 4-12 cultures was measured by the difference between
the two groups in the percentage of cultures classified as resistant (last column).The
largest differences in percentages, indicating the best discrimination, were obtained by
defining resistance as an S1-MIC of 200 µg/ml or more, an S2-MIC of 200 µg/mlor more
or an S3-MIC of 50 µg/ml or more.Further, the actual differences observed with the
three definitionswere approximately equal, being 38 %, 40% and. 42 %, respectively.
However, as the S1-MIC definition classified an unduly high proportion (nearly one-fifth)
of the W+F cultures as resistant and as the S3-MIC could not be determined for an
appreciable proportion of the cultures (about 8 % ), an S2-MIC of 200 µg/mlor more
was chosen as the most satisfactory MIC definition of resistance.
Definitions of resistance based on proportions resistant to different concentrations :The
findings with the proportions resistant to 25 µg/ml, 50 µg/ml and 100 µg/ml pyrazinamide
are presented in Table IV,As with the MICs, the W and F cultures had similar distri-
butions, and the amalgamated group (W+F) was less sensitive than the British cultures
and the strain H37Rv ; however, the differences were smaller than those obtained with
the MICs. Again, PR cultures isolated at 4-6 months and 7-12 months had similar
distributions, and the amalgamated group (PR 4-12 cultures) was substantially less
sensitive than the W+F cultures.
As with the MICs, the findings in W+F cultures and PR 4-12 cultures formed
the basis for evolving definitions of resistance.Several definitions of resistance (Table
IV, column 2) were considered.As the discriminating ability of most of them was of
the same order, the final choice was made by selecting that definition which yielded a
5 % prevalence of resistance in W+F cultures (it will be recalled that the corresponding
proportion was 8 % with the S2-MIC definition).The definitions thus chosen were (a)
proportion of 20 % or more on 25 µg/ml, (b) proportion of 5 % or more on 50 µg/ml
Table IV. Cumulative distributions of cultures according to proportions resistant at 40 days
Concentration of
pyrazinamide
Proportion
resistant
No chemotherapy with pyrazinamide
H37RV British W  F W + F
(%) (%) (%) (%) (%) (a)
Duration (months) of chemotherapy
with pyrazinamide
(PR cultures)
1–3
(%)
4–6 7–-12 4–12
(%) (%) (%) (b)
1% or more
5% or more
10% or more
20% or more
50% or more
No. of cultures 85 21 220 48 268
6 33 44 39
53 51 5O 101
53 so so loo
Measure of
discrimination
(b–a)
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and (c) proportion of 1% or more in 100 µg/ml.The proportion resistant to 100 µg/ml
could not be determined exactly for about 8 % of the cultures ; however, most of these
had values of less than 1% and could therefore be classified as sensitive.
The findings with 12.5 µg/ml pyrazinamide have not been tabulated here as defini-
tions based on them did not discriminate very efficiently between the W+F cultures and
PR 4-12 cultures ; thus, the maximum discrimination obtained was about 30 %, which is
substantially less than the discrimination of 41-45 % obtained with the definitions based
on the tidings with 25, 50 and 100 µg/ml pyrazinamide.
Efficiency of the four chosen definitions of resistance : T ble V summarises the
efficiency of the four chosen definitions of resistance.First, it will be noted that the
percentage of W+F cultures classified as resistant is uniformly small, namely 5-8 %
Secondly, the discriminating ability of the four definitions appears to be fairly similar ;
thus, the difference between the W+F cultures and PR 4-12 cultures in the proportion
of cultures classified as resistant was 40 % with the S2-MIC definition and 41%, 43 % and
45% respectively, with the definitions based on the proportion resistant to 25 µg/ml,
50 µg/ml and 100 µg/ml pyrazinamide.
Table V. Efficiency of chosen definitions of resistance
Percentage classified
as resistant
Definition of resistance
Measure of
discrimination
W+F PR 4-12 (b–a)
cultures* cultures †
(a) (b)
*that is, cultures isolated from Madras patients with no history of treatment with pyrazinamide
†that is, cultures isolated from Madras patients at 4-12 months after the start of daily treatment
with pyrazinamide
Extent of agreement between the findings with the four chosen definitions of resistance :
Table VI studies the extent of agreement between the four chosen definitions of resistan-
ce, considered pair by pair, in the classification of PR cultures as sensitive or resistant.
In general, the extent of agreement was of a high order, the proportion of cultures having
the same classification by both definitions of a pair ranging from 92 % to 99 %.Further-
more, the disagreements appeared to be fairly evenly distributed.It may, herefore,
be concluded that there is little to choose between the four definitions of resistance.
Association between the viable count on acidified drug-free medium and various measures
of sensitivity :Table VII relates the results of pyrazinamide sensitivity tests in W+F
cultures to the growth on the acidified drug-free medium.An S2-MIC of 200 µg/ml
or more (that is, a result classifying the culture as resistant) was obtained for 3 % of 75
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cultures with a viable count of less than 104, 6% of 150 cultures with a viable count
ranging between 104 and 105, and 22% of 40 cultures with a viable count of 105 or
more, a highly significant trend (P< 0.001). Similarly, highly significant trends
(P < 0.001) were obtained with S2-MICs of 100 µg/ml or more and 50 µg/ml or more. It
follows that if the S2-MIC is employed as a measure of sensitivity (it will be recalled
that definitions of resistance based on the S1-MIC and the S3-MIC were unsatisfactory),
high viable counts on the acidified drug-free medium could result in over-estimation
of resistance.
Table VI. Extent of agreement between the different definitions of resistance* in the classification
of PR cultures† as sensitive or resistant
I
Measure of sensitivity
 
Same classification by measuresDifferent classifications
(a) and (b) by measures (a) and (b)
(a) (b)
Total
cultures Resistant Sensitive
Sensitive TotalRes istant  No.  % by (a), by (a),sensitive resistant
by (b) by (b)
S2–MIC Proportion on25 µg/ml 148 93 43 136 92 7 5
S2–MIC Proportion on50 µg/ml 148 95 48 143 97 2 3
S2–MIC Proportion on100 µg/ml 147 97 47 144 98 2 1
Proportion on Proportion on
25 µg/ml 50 µg/ml 154 98 47 145 94 3 6
Proportion on Proportion on
25 µg/ml 100 µg/ml 152 98 46 144 95 3 5
Proportion on Proportion on
50µg/ml 100µg/ml 152 100 50 150 99 2 0
*The definitions were (1) S2-MlC of 200 µg/ml or more, (2) growth of 20% or more on 25 µg/ml,
(3) growth of 5% or more on 50 µg/ml and (4) growth of 1% or more on 100 µg/ml
†That is, cultures isolated from Madras patients at l-12 months after the start of daily treatment
with pyrazinamide
In contrast, there was no evidence of an association between the viable count
and the proportions resistant to 25 µg/ml (Table VII, right half), 50 µg/ml and 100 µg/ml
(analyses not tabulated here).
Findings with duplicate cultures from the same patient : Table VIII examines the
correlation between the S2-MIC results of duplicate W cultures from the same patient.
First, it will be noted that the same result was obtained with the duplicate culture for
162 (80 %) of 203 patients (this proportion is likely to be an over-estimate as three cate-
gories, namely MICs of 12.5, 25 and 50 µg/ml, have been amalgamated).Secondly,
an MIC of 50 µg/ml or less was obtained with the second culture for 152 (90 %) of 169
patients who had an MIC of 50 µg/ml or less with the first culture, as compared with
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only 17 (50 %) of 34 patients who had an MIC of 100 µg/ml or more with the first culture
(P<0.001). This finding suggests that there were consistent differences between the
patients in the sensitivity of their organisms to pyrazinamide.The findings with the
proportion resistant to 100 µg/ml confirm this inference, (Table IX). Thus, of 156 patients
who had a proportion of less than 0.1 % in the first culture, 131(87 %) had a proportion
of less than 0.1 % in the second culture ;the corresponding values were 67% for 24
patients who had 0.1 % to 1% resistant bacilli in the first culture, and 50% for 10
patients who had 1% or more resistant bacilli in the first culture.The trend in these
percentages is highly significant (P<0.01). Significant trends (P< 10-5) were also
obtained with the findings on 25 µg/ml and 50 µg/ml (analyses not tabulated here).
Table VII. Results in W+P cultures* related to growth on acidified drug-free medium
Percentage of cultures
Viable count on Total
acidified drug-free cultures
S2-MIC (µg/ml) Proportion resistant to 25 µg/ml
medium†
†Estimated for the slope inoculated with the standard suspension (S1)
Table VIII. Correlation between results of duplicate W cultures* from the same patient
(S2-MIC). 
MIC (µg/ml) of second culture
MIC (µg/ml) of Total
first culture patients
50 or less 100 200 or more
*That is; cultures isolated from Madras patients with no history of
previous chemotherapy
Of 19 patients whose first culture was classified as resistant by the S2-MIC defini-
tion (namely, 200 µg/ml or more), only 5 had the second culture also classified as resis-
tant by same definition. (Table VIII). The corresponding proportion was 4 of 10,
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when resistance was defined as 1% or more growth on 100 µg/ml (Table IX).Thus,
the proportion of patients who had both cultures resistantwas mall, namely 5 of 203
with the MIC definition and 4 of 190 with the proportion definition.It may, therefore,
be concluded that wild strains with consistent resistance to pyrazinamide did not consti-
tute more than 2-3 % of all wild strains.
Table IX. Correlation between results of duplicate W cultures* from the same patient
(Proportion resistant to 100 µg/ml)
Proportion resistant to 100 µg/ml
Proportion resistant in second culture
to 100 µg/ml in T o t a l
first culture patientsLess than
0.1 % 0.1% – 1% – 5% or more
Total patients 152 26 8 4 190
*That is, cultures isolated from Madras patients with no history of
previous chemotherapy
Emergence of resistance during treatment with a daily regimen containing pyrazinamide :
The pattern of month-by-month sensitivity test results was examined for 10 patients
who repeatedly produced positive cultures during treatment at this centre with a daily
regimen containing pyrazinamide (PR cultures).Two measures of sensitivity, namely,
the S2-MIC and the proportion to 100 µg/ml, were considered (data not tabulated
here).
In six patients, resistance to pyrazinamide emerged at 4, 4, 5, 5, 5 and 7 months,
respectively, by both criteria, namely, S2-MTC of 200 µg/ml or more and 1 % or more
growth on 100 µg/ml ; further, all subsequent cultures were resistant by both the defini-
tions.
In one patient, all the cultures isolated at 1-11 months were sensitive by both
definitions; at 12 months, however, the culture was resistant by the proportion definition
(41%) but sensitive by the MIC definition (25 µg/ml).In the remaining three patients,
there was no evidence, either from the MICs or from the proportions resistant, that
resistance to pyrazinamide had emerged. None of the above four patients was very
regular in taking drugs.
Discussion
Routine determinations of pyrazinamide sensitivity have proved to be difficult in
many laboratories on account of the failure of a proportion of strains of M. tubercul sis
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to grow in a medium whose pH is sufficiently acidic for the activity of the drug to be
demonstrated.The acidified Lowenstein-Jensen medium used in the laboratory was,
however, found to sustain the growth of all but 4 of the 538 strains tested. A great deal
of care was exercised in the preparation of this medium.In particular, a pH meter
with a glass electrode was used to adjust the pH.Next, the inoculum was evenly
distributed over the surface of the soft acid medium, as experience showed that, on
drug-containing slopes, a cluster of small colonies often developed in any area where
the inoculum was locally dense, presumably because the concentration of bacterial
pyrazinamidase in such areas was so high that it destroyed the pyrazinamide and made
the medium more alkaline.Finally, the slopes were incubated at 37°C for 40 days ;
even so, some strains produced minute colonies which were rather difficult to disting-
uish from the medium.In the light of these remarks, it may be concluded that pyra-
zinamide sensitivity tests should be undertaken only in specialized laboratories.
The results of the sensitivity test were expressed as minimal inhibitory concentra-
tions (MICs) for various sizes of the inoculum and as proportions resistant to various
concentrations of pyrazinamide.For ach of these measures, the findings in a population
consisting predominantly of sensitive cultures (obtained from patients with no history
of chemotherapy with pyrazinamide) were compared with those in a population consis-
ting of cultures obtained 4-12 months after the start of daily treatment with the drug;
a definition of resistance was then chosen such that it discriminated efficiently between
the two populations and, furthermore, classified only a small proportion of the former
population (predominantly sensitive) as resistant.
Considering first the various MIC measures, the MIC (10-colony end-point) with
a 1 in 10 dilution of the standard inoculum employed at this Centre provided the most
satisfactory definition of resistance, namely 200 µg/ml or more.Next, there was little
to choose between the proportion definitions, the optimal definitions being 20% or
more on 25 µg/ml, 5 % or more on 50 µg/ml and 1% or more on 100 µg/ml.The defini-
tions recommended by Canetti, Rist and Grosset (1963) are 50% or more on 20 µg/ml
and 10 % or more on 100 µg/ml, employing a 40-day incubation period ; however, the
pH of their Lowenstein-Jensen medium was 5.0 before inspissation, as compared to
4.80-4.85 in the present study.Novak, Feitova and Sytarova (1970) have suggested
a proportion definition of 50% or more on 100 µg/ml, employing a 4-week incubation
period and Lowenstein-Jensen medium with a pre-inspissation pH of 5.27.
The efficiency of the four Madras definitions of resistance was of the same order,
each definition classifying as resistant 5-8 % of the predominantly sensitivegroup of
cultures and 46-50 % of the group of cultures obtained 4-12 months after the start of daily
treatment with pyrazinamide. Furthermore, highly satisfactory agreement, namely
92-99%, was obtained between pairs of definitions in the classification of ind vidual
cultures as sensitive or resistant. Nevertheless, there would appear to be a slight
advantage in employing the proportion definitions as the findings were not influenced by
the viable count on the drug-free acid medium, whereas larger viable counts were
associated with higher MICs. This advantage is, however, offset by the practical
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difficulties in undertaking a more complex test, involving serial dilutions of the
inoculum and the counting of colonies which are sometimes minute.
In patients with no history of previous chemotherapy, a finding of pyrazinamide
resistance in one culture was often not confirmed by the finding in a second culture ;
this suggests, that a single resistant result pretreatment does not always reflect the true
sensitivity of the strain.I  a study of reserve regimens in East Africa (East African/
British Medical Research Council Pyrazinamide Investigation 1969), pyrazinamide
sensitivity tests were set up in a very similar manner to those in the present study.No
association was found between the pretreatment sensitivity of the strains, as measured
by MICs or proportions resistant, and the response to treatment with regimens of
streptomycin plus pyrazinamide.Therefore, in patients with no history of chemothe-
rapy with pyrazinamide, a finding of pyrazinamide resistance in a ingle pretre tment
culture should not be regarded as a contra-indication for treatment with this drug.
Considering next the cultures isolated from patients during daily treatment with
pyrazinamide, resistance was found in 8-9 % of the cultures obtained in the first 3 months,
43-52 % of those obtained at 4-6 months, and 44-49 % of those obtained at 7-12 months
(Tables III and IV).These findings indicate that resistance to pyrazinamide usually
emerged between 4 and 6 months after the start of treatment.This was confirmed by
an examination of the month-by-month sensitivity test results for 10 patients who were
repeatedly culture-positive during treatment.
British cultures were appreciably more sensitive to pyrazinamide than Madras
cultures, when sensitivity to the drug was measured as an MIC; however,when it was
measured as the proportion resistant to different drug concentrations, the differences
were not so appreciable:This may be explained by the fact that colony counts on
drug-free acidified medium were substantially lower for the British cultures than for
the Madras cultures, and the finding that low counts on drug-free acidified medium were
associated with low MICs but had little effect on the proportions resistant.Finally, the
difference between British and Madras strains in their ability to grow on drug-free
acidified medium may be due to the fact that the former were maintained by repeated
sub-cultivation on normal Lowenstein-Jensen medium while the latter were primary
isolates ; it is also possible that the pH of 4.80-4.85,which was found to be the best for
Madras strains, may not be optimal for all strains.
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